跳至主要内容
临床试验/JPRN-UMIN000006208
JPRN-UMIN000006208招募中1 期

Phase I/II trial of neoadjuvant chemotherapy with UFT/Leucovorin and Irinotecan plus radiation in patients with locally advanced rectal cancer. - Phase I/II trial of neoadjuvant chemotherapy with UFT/Leucovorin and Irinotecan plus radiation in patients with locally advanced rectal cancer.

The University of Tokyo Hospital. Department of surgical oncology.0 个研究点目标入组 39 人开始时间: 2011年8月22日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
39

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Allergic to a drug 2.Contraindications to UFT, Leucovorin and Irinotecan 3.Active infection 4.UGT1A: *6/*6, *28/*28 and *6/*28 5.Severe complications such as ileus, interstitial pneumonia, DM, heart failure, lung failure and liver failure 6.Pregnant or planning to get pregnant.

研究者

发起方
The University of Tokyo Hospital. Department of surgical oncology.

相似试验